Atlanta Braves v Washington Nationals - Game Two

Strasburg? Gonzalez? Zimmermann? Fister? Nope, the Nationals’ leader in wins is … Tanner Roark

14 Comments

For all the big-money, big-name starters in the Nationals’ rotation–Stephen Strasburg, Gio Gonzalez, Jordan Zimmermann, Doug Fister–the team leader in both wins and ERA is a little-known 27-year-old sophomore named Tanner Roark.

Roark was drafted in the 25th round by the Rangers in 2008 and came to the Nationals in the mid-2010 trade for Cristian Guzman. He never cracked anyone’s top-100 prospect list and didn’t even debut in the majors until age 26 last season after posting an underwhelming 4.04 ERA in the minors.

And then he went 7-1 with a 1.96 ERA as a rookie and has followed it up by winning a team-high nine games with a 2.91 ERA in 19 starts this season.

Roark doesn’t have overpowering raw stuff with a fastball that averages 91 miles per hour and he’s managed just 6.7 strikeouts per nine innings, but among the 149 pitchers with at least 150 innings since the beginning of last season he ranks 19th in walk rate at 1.9 per nine innings and fifth in home run rate at 0.46 per nine innings. Throwing strikes, keeping the ball in the ballpark, and letting the defense do its job can definitely be a recipe for success.

Chase Hughes of CSNWashington.com has a good article about how Roark went from non-prospect to standout starter, with lots of quotes from his Nationals teammates. It’s a helluva story.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.